End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
10.93
CNY
|
-3.70%
|
|
+15.91%
|
-1.89%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,879
|
6,224
|
6,868
|
14,034
|
8,539
|
6,480
|
Enterprise Value (EV)
1 |
6,730
|
7,132
|
7,830
|
14,833
|
10,438
|
8,230
|
P/E ratio
|
25.2
x
|
271
x
|
115
x
|
23.8
x
|
97.9
x
|
-223
x
|
Yield
|
1.14%
|
0.74%
|
0.33%
|
0.21%
|
0.34%
|
-
|
Capitalization / Revenue
|
1.66
x
|
2.08
x
|
2.07
x
|
2.14
x
|
1.24
x
|
0.89
x
|
EV / Revenue
|
1.9
x
|
2.39
x
|
2.36
x
|
2.26
x
|
1.52
x
|
1.13
x
|
EV / EBITDA
|
10.6
x
|
31.4
x
|
22.2
x
|
16.3
x
|
29
x
|
12.3
x
|
EV / FCF
|
-183
x
|
-46.7
x
|
-347
x
|
-10.7
x
|
-4.36
x
|
1,477
x
|
FCF Yield
|
-0.55%
|
-2.14%
|
-0.29%
|
-9.34%
|
-22.9%
|
0.07%
|
Price to Book
|
2.53
x
|
2.52
x
|
2.77
x
|
3.12
x
|
1.58
x
|
1.07
x
|
Nbr of stocks (in thousands)
|
448,420
|
459,988
|
460,005
|
578,741
|
581,312
|
581,670
|
Reference price
2 |
13.11
|
13.53
|
14.93
|
24.25
|
14.69
|
11.14
|
Announcement Date
|
4/25/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/25/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,544
|
2,986
|
3,315
|
6,569
|
6,862
|
7,296
|
EBITDA
1 |
636.9
|
227
|
352.7
|
909.1
|
360.3
|
669.7
|
EBIT
1 |
555.6
|
115.9
|
212.8
|
767.3
|
160.5
|
323.6
|
Operating Margin
|
15.68%
|
3.88%
|
6.42%
|
11.68%
|
2.34%
|
4.44%
|
Earnings before Tax (EBT)
1 |
446.2
|
19.52
|
67.93
|
652
|
55.75
|
17.56
|
Net income
1 |
220
|
24
|
60.52
|
561.7
|
86.19
|
-27.89
|
Net margin
|
6.21%
|
0.8%
|
1.83%
|
8.55%
|
1.26%
|
-0.38%
|
EPS
2 |
0.5200
|
0.0500
|
0.1300
|
1.020
|
0.1500
|
-0.0500
|
Free Cash Flow
1 |
-36.7
|
-152.9
|
-22.56
|
-1,385
|
-2,395
|
5.571
|
FCF margin
|
-1.04%
|
-5.12%
|
-0.68%
|
-21.08%
|
-34.9%
|
0.08%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.83%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1500
|
0.1000
|
0.0500
|
0.0500
|
0.0500
|
-
|
Announcement Date
|
4/25/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/25/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
851
|
908
|
962
|
798
|
1,898
|
1,750
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.336
x
|
4.001
x
|
2.729
x
|
0.8782
x
|
5.268
x
|
2.614
x
|
Free Cash Flow
1 |
-36.7
|
-153
|
-22.6
|
-1,385
|
-2,395
|
5.57
|
ROE (net income / shareholders' equity)
|
18.4%
|
0.85%
|
2.32%
|
16%
|
1.34%
|
-0.41%
|
ROA (Net income/ Total Assets)
|
7.8%
|
1.5%
|
2.87%
|
7.48%
|
1.02%
|
1.52%
|
Assets
1 |
2,820
|
1,596
|
2,111
|
7,511
|
8,461
|
-1,833
|
Book Value Per Share
2 |
5.190
|
5.370
|
5.390
|
7.760
|
9.310
|
10.40
|
Cash Flow per Share
2 |
1.650
|
0.9000
|
0.8500
|
1.740
|
2.650
|
7.270
|
Capex
1 |
324
|
374
|
192
|
772
|
2,101
|
732
|
Capex / Sales
|
9.14%
|
12.53%
|
5.81%
|
11.76%
|
30.62%
|
10.04%
|
Announcement Date
|
4/25/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/25/23
|
4/24/24
|
|
1st Jan change
|
Capi.
|
---|
| -1.89% | 878M | | +1.20% | 67.6B | | +44.29% | 40.33B | | +15.99% | 38.65B | | +4.67% | 32.55B | | +6.59% | 18.94B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.83B | | -14.74% | 13.79B |
Other Commodity Chemicals
|